India Pharma Outlook Team | Friday, 31 July 2026
MedTech Hub development in India accelerates as a new policy framework and global partnerships reshape the country’s medical technology sector.
The MedTech hub initiative gains momentum with a strategic Memorandum of Understanding (MoU) between Invest India and APACMed. This is expected to drive investment, innovation, and sustainable growth.
The government strengthens regulatory efficiency and promotes ease of doing business to attract global players.
This MedTech hub strategy aligns with national priorities to boost domestic manufacturing and reduce import dependence.
With strong institutional backing and international collaboration, India positions itself as a competitive destination for medical technology advancement and global healthcare supply chains.
The MedTech hub initiative advances through a formal agreement between Invest India, the National Investment Promotion and Facilitation Agency, and the Asia Pacific Medical Technology Association (APACMed).
Both organizations signed the MoU at Bharat Mandapam, New Delhi, to strengthen collaboration between the Government of India and the global MedTech industry. The agreement focuses on facilitating investment inflows, accelerating innovation, and ensuring sustainable growth across the medical technology sector.
Also Read: Driving Vaccine Adoption Beyond Pediatric Immunization in India
Senior leadership reinforced the MedTech hub vision during the MoU exchange. Shri Manoj Joshi, Secretary, Department of Pharmaceuticals, and Dr. M Srinivas, Member, NITI Aayog, attended the event and emphasized coordinated policy execution.
“India’s medical devices sector has witnessed remarkable growth over the past several years, driven by increasing healthcare demand, expanding healthcare infrastructure, the Production Linked Incentive (PLI) Scheme and other supportive policy interventions. As we move forward, we need our medical devices sector to evolve into a more robust and well-regulated ecosystem that promotes quality, patient safety and global competitiveness” said Shri Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
The government continues to align regulatory frameworks with industry requirements to create a stable and transparent environment. This approach strengthens institutional support and accelerates decision-making for MedTech investments.
The MedTech hub strategy leverages global partnerships to integrate international expertise into India’s healthcare ecosystem. APACMed brings industry knowledge, regional networks, and innovation capabilities that support technology transfer and collaborative research.
These partnerships enable Indian companies to scale advanced manufacturing and adopt global best practices. The initiative also improves market access for international players, strengthening India’s role in global MedTech supply chains.
The MedTech hub benefits from a new policy direction focused on simplifying regulations and improving ease of doing business. Authorities streamline approval processes and encourage industry participation through structured engagement.
This policy environment attracts foreign direct investment and supports domestic enterprises in expanding production capabilities. The initiative directly contributes to reducing import dependency while strengthening local manufacturing infrastructure.
The MedTech hub initiative positions India as a high-growth destination for medical technology innovation and manufacturing. Strong collaboration between government bodies and global industry leaders ensures sustained sectoral expansion.
The MoU marks a critical step in building a resilient and competitive MedTech ecosystem. Continued focus on policy support, investment facilitation, and global partnerships will drive long-term growth and improve healthcare accessibility across India.
